SCHEMBL2195079

SCHEMBL2195079

CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H]([C]=O)Cc1c[nH]c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERAP2 Q6P179 5/20 0.49
▸ IL1RN P18510 5/20 0.48
▸ MMP2 P08253 8/20 0.47
▸ MMP1 P03956 4/20 0.47
▸ KISS1R Q969F8 4/20 0.47
▸ MMP9 P14780 5/20 0.47
▸ MMP8 P22894 5/20 0.47
▸ ADAM10 O14672 1/20 0.46
▸ ADAM12 O43184 1/20 0.46
▸ ADAMTS4 O75173 1/20 0.46
▸ MMP3 P08254 1/20 0.46
▸ MMP7 P09237 1/20 0.46
▸ MMP12 P39900 1/20 0.46
▸ MMP13 P45452 1/20 0.46
▸ MMP14 P50281 1/20 0.46
▸ MMP15 P51511 1/20 0.46
▸ MMP16 P51512 1/20 0.46
▸ ADAM17 P78536 1/20 0.46
▸ ADAM9 Q13443 1/20 0.46
▸ MMP26 Q9NRE1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2193233 0.88 UTS2R (0.52) MMP2MMP1KISS1RMMP9MMP8
SCHEMBL29427859 0.86 ERAP2 (0.63) ERAP2IL1RNMMP2MMP9MMP8
SCHEMBL2181812 0.84 BACE1 (0.34) MMP1KISS1RMMP8
SCHEMBL2183848 0.84 CTSC (0.56) MMP2MMP1KISS1RMMP9MMP8
SCHEMBL30500405 0.84 ECE1 (0.59) ERAP2IL1RNMMP2MMP1MMP9
SCHEMBL29516260 0.84 ERAP2 (0.61) ERAP2IL1RNECE1ERAP1
SCHEMBL11749300 0.84 CTSC (0.48) ERAP2IL1RNMMP2MMP1MMP9
SCHEMBL2183785 0.82 GHSR (0.48) MMP2MMP1MMP9MMP8
SCHEMBL30506397 0.82 ERAP2 (0.59) ERAP2IL1RNECE1ERAP1
SCHEMBL30656926 0.81 MMP2 (0.40) MMP2MMP1KISS1RMMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9173951-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2015-11-03 — — US disclosed
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2015-02-19 — — US disclosed
US-8680263-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2014-03-25 — — US disclosed
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST ERAP2 1822/4885IL1RN 3251/4885MMP2 627/4885
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST ERAP2 1822/4885IL1RN 3251/4885MMP2 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback